Treats major depressive disorder (MDD). ANDA 72193, held by Oxford Pharms. Trazodone Hydrochloride.
As of Nov 16, 2026, ANDA 72193 (Trazodone Hydrochloride), held by Oxford Pharms, was first approved by FDA on Feb 2, 1989, with 31 approved supplements and 0 published complete response letters.
Trazodone hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Feb 2, 1989 | Original application | Approved | None posted |
| Trazodone Hydrochloride100MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Trazodone Hydrochloride25MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Trazodone Hydrochloride75MG · tablet;oral | Trazodone Hydrochloride | Rx |
| Jun 24, 2025 | Supplement 58Labeling · Standard review | Approved | None posted |
| May 19, 2020 | Supplement 56Labeling · Standard review | Approved | None posted |
| May 19, 2020 | Supplement 53Labeling · Standard review | Approved | None posted |
| Jun 5, 2015 | Supplement 48Labeling · Standard review | Approved | None posted |
| May 12, 2015 | Supplement 41Manufacturing | Approved | None posted |
| Oct 29, 2007 | Supplement 40Labeling | Approved | None posted |
| Jun 26, 2007 | Supplement 39Labeling | Approved | None posted |
| Aug 15, 2005 | Supplement 37Labeling | Approved | None posted |
| Jan 5, 2005 | Supplement 31Labeling | Approved | None posted |
| Dec 26, 2002 | Supplement 29Labeling | Approved | None posted |
| Feb 19, 2002 | Supplement 28Manufacturing | Approved | None posted |
| Dec 13, 2001 | Supplement 27Manufacturing | Approved | None posted |
| Jan 4, 2001 | Supplement 26Labeling | Approved | None posted |
| May 26, 2000 | Supplement 23Labeling | Approved | None posted |
| May 26, 2000 | Supplement 22Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 25Manufacturing | Approved | None posted |
| Dec 2, 1999 | Supplement 24Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 15Manufacturing | Approved | None posted |
| Feb 12, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Feb 18, 1998 | Supplement 13Manufacturing | Approved | None posted |
| Oct 9, 1997 | Supplement 12Manufacturing | Approved | None posted |
| May 7, 1997 | Supplement 11Manufacturing | Approved | None posted |
| Dec 11, 1996 | Supplement 10Manufacturing | Approved | None posted |
| Aug 16, 1996 | Supplement 9Manufacturing | Approved | None posted |
| Apr 30, 1996 | Supplement 8Manufacturing | Approved | None posted |
| May 5, 1993 | Supplement 7Manufacturing | Approved | None posted |
| Apr 6, 1992 | Supplement 5Manufacturing | Approved | None posted |
| Apr 6, 1992 | Supplement 3Manufacturing | Approved | None posted |
| Mar 4, 1992 | Supplement 6Labeling | Approved | None posted |
| Sep 13, 1991 | Supplement 4Labeling | Approved | None posted |
| Jun 25, 1991 | Supplement 2Manufacturing | Approved | None posted |
| Feb 2, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters